Brief: India's Strides Pharma Science June-Qtr Consol Net Loss Narrows
29/07/2022 08:41
July 29 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* INDIA'S STRIDES PHARMA SCIENCE JUNE-QUARTER CONSOL NET LOSS 1.36 BILLION RUPEES VERSUS
LOSS 2.05
BILLION RUPEES YEAR AGO
* STRIDES PHARMA SCIENCE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 9.4 BILLION RUPEES
VERSUS
6.88 BILLION RUPEES YEAR AGO
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees